143 related articles for article (PubMed ID: 20198329)
1. Carvedilol in glioma treatment alone and with imatinib in vitro.
Erguven M; Yazihan N; Aktas E; Sabanci A; Li CJ; Oktem G; Bilir A
Int J Oncol; 2010 Apr; 36(4):857-66. PubMed ID: 20198329
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
Bilir A; Erguven M; Oktem G; Ozdemir A; Uslu A; Aktas E; Bonavida B
Int J Oncol; 2008 Apr; 32(4):829-39. PubMed ID: 18360710
[TBL] [Abstract][Full Text] [Related]
3. Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma.
O'Reilly T; Wartmann M; Maira SM; Hattenberger M; Vaxelaire J; Muller M; Ferretti S; Buchdunger E; Altmann KH; McSheehy PMJ
Cancer Chemother Pharmacol; 2005 Apr; 55(4):307-317. PubMed ID: 15723258
[TBL] [Abstract][Full Text] [Related]
4. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
Shingu T; Fujiwara K; Bögler O; Akiyama Y; Moritake K; Shinojima N; Tamada Y; Yokoyama T; Kondo S
Int J Cancer; 2009 Mar; 124(5):1060-71. PubMed ID: 19048625
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.
Pessetto ZY; Ma Y; Hirst JJ; von Mehren M; Weir SJ; Godwin AK
Mol Cancer Ther; 2014 Oct; 13(10):2276-87. PubMed ID: 25122069
[TBL] [Abstract][Full Text] [Related]
8. [Effect of imatinib at different concentrations on rat C6 glioma cell apoptosis and cell cycle].
Yang L; Xu ZY; Chen XH; Wang KW; Li GF; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1089-91. PubMed ID: 20501402
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells.
Kim JH; Song M; Kang GH; Lee ER; Choi HY; Lee C; Kim JH; Kim Y; Koo BN; Cho SG
Leuk Res; 2012 Sep; 36(9):1157-64. PubMed ID: 22770910
[TBL] [Abstract][Full Text] [Related]
11. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells.
Tzadok S; Beery E; Israeli M; Uziel O; Lahav M; Fenig E; Gil-Ad I; Weizman A; Nordenberg J
Int J Oncol; 2010 Oct; 37(4):1043-51. PubMed ID: 20811727
[TBL] [Abstract][Full Text] [Related]
12. Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay.
Kinsella P; Clynes M; Amberger-Murphy V
J Neurooncol; 2011 Jan; 101(2):189-98. PubMed ID: 20512610
[TBL] [Abstract][Full Text] [Related]
13. ABC transporters and the accumulation of imatinib and its active metabolite CGP74588 in rat C6 glioma cells.
Declèves X; Bihorel S; Debray M; Yousif S; Camenisch G; Scherrmann JM
Pharmacol Res; 2008 Mar; 57(3):214-22. PubMed ID: 18337118
[TBL] [Abstract][Full Text] [Related]
14. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
[TBL] [Abstract][Full Text] [Related]
16. Enhanced proliferation inhibition and apoptosis in glioma cells elicited by combination of irinotecan and imatinib.
Lu J; Hu Y; Qian R; Zhang Y; Yang X; Luo P
Eur J Pharmacol; 2020 May; 874():173022. PubMed ID: 32084420
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide.
Liu X; Yang JM; Zhang SS; Liu XY; Liu DX
BMC Cancer; 2010 Dec; 10():684. PubMed ID: 21159181
[TBL] [Abstract][Full Text] [Related]
18. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
Wietrzyk J; Milczarek M; Kutner A
Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]